We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Orders Alphatec to Submit Revised Postmarket Protocol
FDA Orders Alphatec to Submit Revised Postmarket Protocol
January 19, 2011
Time is running out for Alphatec Spine to submit a revised protocol for required postmarket surveillance studies for three of its devices, the FDA says in a warning letter.